Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Anhydrous Tolmetin Sodium
2. Anhydrous, Tolmetin Sodium
3. Dihydrate Tolmetin Sodium
4. Mcn 2559
5. Mcn-2559
6. Mcn2559
7. Sodium Anhydrous, Tolmetin
8. Sodium, Tolmetin
9. Tolectin
10. Tolmetin
11. Tolmetin Sodium Anhydrous
12. Tolmetin Sodium, Anhydrous
13. Tolmetin Sodium, Dihydrate
1. 35711-34-3
2. Sodium Tolmetin
3. Tolmetin Sodium Anhydrous
4. Tolmetin (sodium)
5. Sodium 2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetate
6. Sodium 1-methyl-5-(4-methylbenzoyl)-1h-pyrrole-2-acetate
7. Tolmetin Sodium Salt Dihydrate
8. Chebi:9619
9. Sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate
10. Sodium 1-methyl-5-p-toluoylpyrrole-2-acetate
11. Wl259637kx
12. Toleclin
13. 1h-pyrrole-2-acetic Acid, 1-methyl-5-(4-methylbenzoyl)-, Sodium Salt
14. Tolectin Ds
15. Tolectin 600
16. Einecs 252-687-3
17. Tolmetin Sodium Salt
18. Nsc-757341
19. Mcn-2559-21-98
20. Unii-wl259637kx
21. 1-methyl-5-(p-toluoyl)-2-pyrroleacetic Acid
22. Spectrum1500582
23. Schembl1477674
24. Chembl1200613
25. Dtxsid2091546
26. Hms500k15
27. Hy-b1799a
28. Tolmetin Sodium [who-dd]
29. Hms1921e19
30. Hms2092o03
31. 1h-pyrrole-2-acetic Acid, 1-methyl-5-(p-toluoyl)-, Sodium Salt
32. Ccg-39123
33. Akos015901707
34. Akos015961034
35. Ncgc00094796-01
36. Ncgc00094796-02
37. Ac-12807
38. Cs-0013840
39. C02328
40. 4-amino-2-methoxy-5-mercaptobenzoicacid
41. Ab01566945_01
42. W-110866
43. Q27108450
44. Sodium [1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl]acetate
45. 1h-pyrrole-2-acetic Acid, 1-methyl-5-(4-methylbenzoyl)-, Sodium Salt (1:1)
Molecular Weight | 279.27 g/mol |
---|---|
Molecular Formula | C15H14NNaO3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 279.08713759 g/mol |
Monoisotopic Mass | 279.08713759 g/mol |
Topological Polar Surface Area | 62.1 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 353 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Tolmetin sodium |
Drug Label | Each capsule, for oral administration, contains 492 mg of tolmetin sodium (as the dihydrate), equivalent to 400 mg of tolmetin. Each capsule contains 36 mg (1.56 mEq) of sodium. Each capsule contains the following inactive ingredients: colloidal sili... |
Active Ingredient | Tolmetin sodium |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 200mg base; eq 600mg base; eq 400mg base |
Market Status | Prescription |
Company | Teva; Mutual Pharm; Mylan |
2 of 2 | |
---|---|
Drug Name | Tolmetin sodium |
Drug Label | Each capsule, for oral administration, contains 492 mg of tolmetin sodium (as the dihydrate), equivalent to 400 mg of tolmetin. Each capsule contains 36 mg (1.56 mEq) of sodium. Each capsule contains the following inactive ingredients: colloidal sili... |
Active Ingredient | Tolmetin sodium |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 200mg base; eq 600mg base; eq 400mg base |
Market Status | Prescription |
Company | Teva; Mutual Pharm; Mylan |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tolmetin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tolmetin Sodium, including repackagers and relabelers. The FDA regulates Tolmetin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tolmetin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tolmetin Sodium supplier is an individual or a company that provides Tolmetin Sodium active pharmaceutical ingredient (API) or Tolmetin Sodium finished formulations upon request. The Tolmetin Sodium suppliers may include Tolmetin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Tolmetin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tolmetin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Tolmetin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Tolmetin Sodium DMFs exist exist since differing nations have different regulations, such as Tolmetin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tolmetin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Tolmetin Sodium USDMF includes data on Tolmetin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tolmetin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tolmetin Sodium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tolmetin Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tolmetin Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tolmetin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tolmetin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tolmetin Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tolmetin Sodium suppliers with NDC on PharmaCompass.
Tolmetin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tolmetin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tolmetin Sodium GMP manufacturer or Tolmetin Sodium GMP API supplier for your needs.
A Tolmetin Sodium CoA (Certificate of Analysis) is a formal document that attests to Tolmetin Sodium's compliance with Tolmetin Sodium specifications and serves as a tool for batch-level quality control.
Tolmetin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Tolmetin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tolmetin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Tolmetin Sodium EP), Tolmetin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tolmetin Sodium USP).
LOOKING FOR A SUPPLIER?